Investigação do papel de SIGIRR/IL-1R8 no crosstalk entre células tumorais e o infiltrado leucocitário

Investigação do papel de SIGIRR/IL-1R8 no crosstalk entre células tumorais e o infiltrado leucocitário

Células tumorais desenvolvem diversas estratégias para escapar da identificação e eliminação pelo sistema imune. Dessa forma, a investigação dos mecanismos envolvidos na comunicação celular no microambiente tumoral e na desregulação local do sistema imune é crítica para uma melhor compreensão da...

Full description

Bibliographic Details
Main Author:	Luís Felipe Ingrássia Campesato
Other Authors:	Anamaria Aranha Camargo
Language:	Portuguese
Published:	Universidade de São Paulo 2015
Subjects:	Biologia molecular Câncer de mama ErbB2/HER2 ILRs Resposta imune antitumoral SIGIRR/IL-1R8 TLRs Antitumor immunity Breast tumors Molecular biology SIGIRR
Online Access:	http://www.teses.usp.br/teses/disponiveis/46/46131/tde-05042016-140157/

Similar Items

Investigação do papel de SIGIRR/IL-1R8 no crosstalk entre células tumorais e o infiltrado leucocitário
by: Campesato, Luís Felipe Ingrássia
Published: (2015)

Estudo comparativo entre os métodos LSAB®+ e Herceptest® para a detecção de HER-2/neu em carcinoma de mama A comparative study between LSAB®+ and Herceptest® in the detection of HER-2/neu in breast carcinoma
by: Alexandre de Oliveira Sales, et al.
Published: (2004-08-01)

Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis
by: Amir Shamshirian, et al.
Published: (2020-10-01)

Alcohol and Cancer Stem Cells
by: Mei Xu, et al.
Published: (2017-11-01)

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance
by: Tameka A Bailey, et al.
Published: (2011-01-01)

Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study
by: Barbara Brunetti, et al.
Published: (2021-04-01)

Trastuzumab em pacientes com câncer de mama her-2 positivo : um estudo sobre os diferentes escores de avaliação laboratorial do gene her-2/neu
by: Dal Lago, Lissandra
Published: (2007)

Trastuzumab em pacientes com câncer de mama her-2 positivo : um estudo sobre os diferentes escores de avaliação laboratorial do gene her-2/neu
by: Dal Lago, Lissandra
Published: (2007)

Trastuzumab em pacientes com câncer de mama her-2 positivo : um estudo sobre os diferentes escores de avaliação laboratorial do gene her-2/neu
by: Dal Lago, Lissandra
Published: (2007)

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
by: Takuya Osada, et al.
Published: (2018-08-01)

Association between serum HER2/ErbB2 levels and coronary artery disease: a case–control study
by: Wen Jian, et al.
Published: (2020-03-01)

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
by: Angela Dalia Ricci, et al.
Published: (2021-04-01)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim, et al.
Published: (2021-08-01)

Mcl-1 in breast cancer: regulation by the EGF receptor family and role in cell survival and drug resistance
by: Booy, Evan Paul
Published: (2011)

Mcl-1 in breast cancer: regulation by the EGF receptor family and role in cell survival and drug resistance
by: Booy, Evan Paul
Published: (2011)

Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family
by: Anton Arkhipov, et al.
Published: (2013-07-01)

Assessment of HER-2 status in invasive breast cancer in Brazil
by: Victor Eduardo Arrua Arias, et al.

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking
by: Coppola C, et al.
Published: (2016-11-01)

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
by: Arik Durcker, et al.
Published: (2020-10-01)

Airway Epithelial Dysfunction in Asthma: Relevant to Epidermal Growth Factor Receptors and Airway Epithelial Cells
by: Hideki Inoue, et al.
Published: (2020-11-01)

Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007)

Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007)

Expressão imunohistoquímica de Her-2/Neu-CerbB-2 e EGFR na mucosa gástrica de pacientes portadores de adenocarcinoma de estômago
by: Cirne Lima, Fernando Krebs
Published: (2007)

Analyse des isoformes du récepteur tyrosine kinase HER4 : vers un ciblage thérapeutique à l’aide d’anticorps en cancérologie
by: Lanotte, Romain
Published: (2018)

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
by: Laura L. Michel, et al.
Published: (2020-10-01)

Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory Upregulation of Other HER Family Members: Basis for Acquired Resistance and for Combination Therapy
by: Daniela Gutsch, et al.
Published: (2021-01-01)

Correlation between resistance to trastuzumab and miR-141 relative expression in the BT-474 human breast cancer cell line
by: Zohreh Rezaei, et al.
Published: (2017-10-01)

Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2<sup>pos</sup> Breast Cancer
by: Loral E. Showalter, et al.
Published: (2021-09-01)

A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo
by: Zheng Yan, et al.
Published: (2021-10-01)

ErbB1-dependent signalling and vesicular trafficking in primary afferent nociceptors associated with hypersensitivity in neuropathic pain
by: Rory Mitchell, et al.
Published: (2020-08-01)

The under-appreciated promiscuity of the epidermal growth factor receptor family.
by: Sean P Kennedy, et al.
Published: (2016-08-01)

ON THE NOTION OF SYNERGY OF MONOCLONAL ANTIBODIES AS DRUGS
by: Michael Sela
Published: (2013-08-01)

Perfil da expressão imunoistoquímica dos receptores da família ErbB e seu prognóstico em pacientes com câncer de cólon e reto com alto risco para recorrência após cirurgia radical
by: Glauco Baiocchi Neto
Published: (2008)

Perfil da expressão imunoistoquímica dos receptores da família ErbB e seu prognóstico em pacientes com câncer de cólon e reto com alto risco para recorrência após cirurgia radical
by: Baiocchi Neto, Glauco
Published: (2008)

Discerning the Role of LMO4 as a Global Modulator of G2/M Cell Cycle Progression and Centrosome Cycle in Breast Cancer Cells
by: Montanez-Wiscovich, Marjorie E.
Published: (2010)

Cytotoxic effects of the dual ErbB tyrosine kinase inhibitor, lapatinib, onwalker 256 rat breast tumour and IEC-6 rat normal small intestinal cell lines
by: Dorothy Keefe, et al.
Published: (2020)

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells
by: Martina S. J. McDermott, et al.
Published: (2019-02-01)

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans
by: Marco Macagno, et al.
Published: (2011-08-01)

Prognostic significance of c-erbB-2 and p53 expression in colorectal carcinoma
by: Aynur Albayrak, et al.
Published: (2014-03-01)

Expression and function of Neuregulin 1 and its signaling system ERBB2/3 in the enteric nervous system
by: Martina eBarrenschee, et al.
Published: (2015-09-01)